Gastroenterology and Hepatology Department, Hamad Medical Corporation, Doha, Qatar.
Public Health Department, Ministry of Public Health, Doha, Qatar.
East Mediterr Health J. 2019 Jul 24;25(5):362-365. doi: 10.26719/emhj.18.046.
Since the development and approval of new direct-acting antiviral (DAA) drugs, chronic hepatitis C virus (HCV) infection is now considered a curable disease. However, the emphasis on DAA therapies might disregard other preventive measures, and limits the strategy for a clinical cure rather than comprehensive disease control. The Qatar National plan for HCV control was launched in December 2014 to prioritize and proactively manage HCV with the ultimate aim of eliminating viral hepatitis. The plan is based on four pillars: primary prevention, early detection, clinical management, and continuous monitoring. This report describes the activities undertaken in Qatar to prepare for the programme and the early results of its initial phase, given the fact that countries with comprehensive HCV plans are providing better access to care and prevention.
自新型直接作用抗病毒（DAA）药物问世并获得批准以来，慢性丙型肝炎病毒（HCV）感染现已被视为可治愈的疾病。然而，对 DAA 疗法的重视可能会忽视其他预防措施，将治疗重点局限于临床治愈，而非全面的疾病控制。卡塔尔国家 HCV 控制计划于 2014 年 12 月启动，旨在对 HCV 进行优先排序和主动管理，最终目标是消除病毒性肝炎。该计划基于四大支柱：初级预防、早期发现、临床管理和持续监测。鉴于全面 HCV 计划的国家可提供更好的护理和预防服务，本报告描述了卡塔尔在为该计划做准备方面所开展的活动以及该计划初始阶段的初步结果。
